Bristol-Myers Squibb Company
BMY
$49.02
$0.5551.15%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.42B | -8.95B | -7.26B | -6.54B | -6.15B |
| Total Depreciation and Amortization | 7.76B | 9.65B | 10.25B | 10.09B | 9.91B |
| Total Amortization of Deferred Charges | 330.00M | -28.00M | -28.00M | -28.00M | -- |
| Total Other Non-Cash Items | 2.06B | 13.71B | 11.65B | 11.67B | 10.32B |
| Change in Net Operating Assets | -1.26B | 810.00M | 389.00M | -1.03B | -356.00M |
| Cash from Operations | 14.31B | 15.19B | 15.00B | 14.16B | 13.72B |
| Capital Expenditure | -1.22B | -1.25B | -1.20B | -1.22B | -1.22B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1.85B | -21.82B | -22.36B | -22.33B | -21.14B |
| Divestitures | 1.10B | 1.10B | 1.01B | 999.00M | 923.00M |
| Other Investing Activities | -264.00M | 618.00M | 46.00M | -141.00M | -267.00M |
| Cash from Investing | -2.23B | -21.35B | -22.50B | -22.69B | -21.70B |
| Total Debt Issued | 384.00M | 15.97B | 20.60B | 20.49B | 20.28B |
| Total Debt Repaid | -5.87B | -5.87B | -7.99B | -5.25B | -2.36B |
| Issuance of Common Stock | -- | -- | 25.00M | 27.00M | 27.00M |
| Repurchase of Common Stock | -- | -- | 0.00 | -4.00B | -4.91B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.91B | -4.86B | -4.81B | -4.78B | -4.76B |
| Other Financing Activities | -112.00M | -106.00M | -87.00M | -64.00M | -5.00M |
| Cash from Financing | -10.51B | 5.13B | 7.74B | 6.43B | 8.28B |
| Foreign Exchange rate Adjustments | -26.00M | -137.00M | 88.00M | -27.00M | -13.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.54B | -1.17B | 325.00M | -2.13B | 286.00M |